Jafron Biomedical Co.,Ltd. (SHE: 300529)
China
· Delayed Price · Currency is CNY
28.71
-0.13 (-0.45%)
Jan 3, 2025, 3:04 PM CST
Jafron Biomedical Co.,Ltd. Company Description
Jafron Biomedical Co.,Ltd. engages in the research, development, production, and sales of blood purification products for hemadsorption industry in China and internationally.
The company offers solutions for ESRD diseases, acute poisoning, critical illness, hepatopathy, immunological disorders, kidney, and liver diseases; HA series hemoperfusion cartridge, BS bilirubin adsorption column and DNA immunoadsorption column, hemoperfusion machine, and blood purification machine; and other products, such as hemodialyzer, hemodialysis concentrate, disinfectants, resin bandages, online hemodialysis powder bag/bucket, and adsorbable suture with needles.
The company was founded in 1989 and is based in Zhuhai, China.
Jafron Biomedical Co.,Ltd.
Country | China |
Founded | 1989 |
Industry | Medical Devices |
Sector | Healthcare |
Employees | 2,408 |
CEO | Fan Dong |
Contact Details
Address: No. 98 Technology Six Road Zhuhai, 519085 China | |
Phone | 86 75 6368 9708 |
Website | jafroninternational.com |
Stock Details
Ticker Symbol | 300529 |
Exchange | Shenzhen Stock Exchange |
Fiscal Year | January - December |
Reporting Currency | CNY |
ISIN Number | CNE100002995 |
SIC Code | 3842 |
Key Executives
Name | Position |
---|---|
Fan Dong | Chairman of Board of Directors and GM |
Xueyun Liao | Director and Financial Director |
De Zhi Li | Deputy General Manager |
Xian Min Tang | Deputy GM and Director |
Aijun Wu | Deputy General Manager |
Rui Wang | General Manager |
Cong Huang | Board Secretary |